Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | Methyl iodide | HCID 6328 | — |
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | Sodium Bicarbonate | HCID 516892 | — |
| Reactant | HCID 136216145 | HCID 136216145 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Solvent | Dichloromethane ethylacetate | HCID 21226138 | — |
| Product | HCID 86724090 | HCID 86724090 | 39% |
Reaction Steps
To 4-(2,4-dichlorophenyl)-1,3,6,6-tetramethyl-7,8-dihydro-4H-pyrazolo[3,4-e][1,4]thiazepine (0.12 g, 0.33 mmol, Example #D.4) dissolved in DMF (10 mL), was added NaH (0.133 g, 3.33 mmol, 60% dispersion in mineral oil) and methyl iodide (0.21 mL, 3.33 mmol). The reaction mixture was stirred for about 24 h at rt. To the reaction mixture was added 5% aqueous sodium bicarbonate (30 mL) and ethyl acetate (25 mL). The layers were separated and the organic layer was washed with water (25 mL), dried (MgSO4), filtered and concentrated in vacuo. The resulting residue was purified by column chromatography (SiO2, ethyl acetate/DCM (1:9 followed by 1:4)), to 4-(2,4-dichlorophenyl)-1,3,6,6,8-pentamethyl-4,7-dihydropyrazolo[3,4-e]thiazepine (0.07 g, 0.189 mmol, 57%), which was dissolved in ethyl acetate and converted into the HCl salt (using 1M HCl/ethanol). The precipitated solid is collected by filtration and washed with a small amount of diethyl ether to afford 4-(2,4-dichlorophenyl)-1,3,6,6,8-pentamethyl-4,7-dihydropyrazolo[3,4-e][1,4]thiazepine hydrochloride (0.053 g, 0.13 mmol, 39%) as an off white solid. LC-MS (Table 1, Method d) Rr=3.05 min, m/z 370 (M+H)+
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09150592B2 |
|---|
| Source dataset | uspto-grants-2015_10 |
|---|
| ORD ID | ord-4083d2593d7f46aaa022b9ec5765f66a |
|---|
| Source note | uspto-grants-2015_10 |
|---|